SCP
CVS icon

Sender Company & Partners’s CVS Health CVS Stock Holding History

Sender Company & Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,331
Closed -$299K – 493
2025
Q2 		$299K Buy
+4,331
New +$284K 0.08% 201
2022
Q2 		– Sell
-12,018
Closed -$1.22M – 32
2022
Q1 		$1.22M Buy
+12,018
New +$1.26M 1.3% 18

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sender Company & Partners's CVS Position: Q3 2025 in Review

Sender Company & Partners sold out of CVS Health (CVS) in Q3 2025, closing a stake of 4,331 shares — an estimated $299K sold.

Sender Company & Partners first reported a position in CVS in Q1 2022 and held it in 2 quarters. The position peaked at $1.22M in Q1 2022. 1,834 funds tracked by Wall St. Rank hold CVS as of Q3 2025.

  • Sender Company & Partners reported no remaining CVS Health position as of Q3 2025 after selling out during the quarter.
  • Sender Company & Partners sold 4,331 CVS Health shares in Q3 2025, an estimated $299K.
  • Sender Company & Partners first reported a position in CVS Health in Q1 2022 and held it in 2 quarters.
  • Sender Company & Partners's CVS Health position peaked at $1.22M in Q1 2022.
  • 1,834 funds tracked by Wall St. Rank held CVS Health as of Q3 2025.

Based on Sender Company & Partners's 13F filing for Q3 2025, filed 17 Nov 2025.